Research programme: anticancer monoclonal antibodies - MedImmuneAlternative Names: Anti-B7-H1 monoclonal antibodies - MedImmune
Latest Information Update: 11 Apr 2012
At a glance
- Originator MedImmune
- Class Monoclonal antibodies
- Mechanism of Action CD274 antigen inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 11 Apr 2012 Preclinical development is ongoing in United Kingdom